Prevalencia, causas y tratamiento de la depresión mayor
Open Access
- 14 June 2017
- journal article
- Published by Autonomous University of Yucatan in REVISTA BIOMÉDICA
- Vol. 28 (2)
Abstract
ResumenLa depresión mayor representa un problema de salud pública debido a su alta prevalencia. La etiología de la depresión es compleja, en ella intervienen factores psicosociales, genéticos, y biológicos. Entre los factores psicosociales, se ha observado que los primeros episodios depresivos aparecen después de algún evento estresante, y el estrés que acompaña al primer episodio produce cambios a largo plazo en la fisiología cerebral. Estos cambios de larga duración pueden producir variaciones a nivel estructural y en el funcionamiento de diferentes áreas cerebrales. Entre los factores genéticos que intervienen en la enfermedad depresiva, se ha reportado que alrededor de 200 genes están relacionados con el trastorno depresivo mayor. Dentro de los factores biológicos, existen evidencias de alteraciones a nivel de neurotransmisores, citosinas y hormonas, cuyas acciones inducen modificaciones estructurales y funcionales en el sistema nervioso central, en el sistema inmunológico y en el sistema endocrino, que incrementan el riesgo de padecer la depresión mayor. A pesar de años de estudio, las bases biológicas de la depresión mayor y el mecanismo preciso de la eficacia antidepresiva siguen siendo poco claras. Los objetivos de la presente revisión son el resumir las principales conclusiones de la literatura clínica y experimental en relación con la etiología del trastorno depresivo mayor.Palabras claveDepresión mayor, neurotransmisores, neuroplasticidad, serotonina, norepinefrina, sistema inmune. AbstractMajor depression represents a public health problem due to its high prevalence. The etiology of major depression is complex because involves psychosocial, genetic, and biological factors. Among psychosocial factors, different studies report that the first depressive episode appear after some stressful event and produces long-term changes in brain physiology. These long-lasting changes produce variations at the structural level and in the functioning of different brain areas. Among the genetic factors involved in depressive illness, it has been reported that about 200 genes are related to major depressive disorder. Within the biological factors, there is an evidence of alterations in the level of neurotransmitters, cytosine’s and hormones, whose actions induces structural and functional modifications in the central nervous system, the immune system and the endocrine system, which increases the risk of suffering major depression. Despite years of study, the biological basis of major depression and precise mechanisms of antidepressant efficacy remain unclear. The objective of the present review is to summarize the main conclusions of the clinical and experimental literature regarding to the etiology of major depressive disorder.Key wordsMajor depression, neurotransmitters, neuroplasticity, serotonin, norepinephrine, immune system.Keywords
This publication has 144 references indexed in Scilit:
- Altered DNA methylation status of human brain derived neurotrophis factor gene could be useful as biomarker of depressionAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2014
- Unipolar depression and hippocampal volume: Impact of DNA sequence variants of the glucocorticoid receptor geneAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Reduced Prefrontal Glutamate/Glutamine and γ-Aminobutyric Acid Levels in Major Depression Determined Using Proton Magnetic Resonance SpectroscopyArchives of General Psychiatry, 2007
- Cognitive Therapy vs Medications in the Treatment of Moderate to Severe DepressionArchives of General Psychiatry, 2005
- Altered Gene Expression of Brain-Derived Neurotrophic Factor and Receptor Tyrosine Kinase B in Postmortem Brain of Suicide SubjectsArchives of General Psychiatry, 2003
- Reduced Glial Cell Density and Neuronal Size in the Anterior Cingulate Cortex in Major Depressive DisorderArchives of General Psychiatry, 2001
- Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric DisordersArchives of General Psychiatry, 2000
- Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance SpectroscopyArchives of General Psychiatry, 1999
- Venlafaxine: A novel antidepressant that has a dual mechanism of actionDepression, 1996
- Treatment of Depression With Cognitive Therapy and AmitriptylineArchives of General Psychiatry, 1985